50% OFF SITEWIDE · Orders before 4PM PST ship same day
50% OFF SITEWIDEOrders before 4PM PST ship same day
Science

The Melanocortin Receptor Family: A Guide for Research

Two researchers examining samples under a light microscope in a research laboratory

The melanocortin system is a masterclass in receptor biology: one parent hormone family signaling through five receptor subtypes, each governing different physiology. Four research compounds in our catalog map onto this system, and knowing which engages which receptor is essential for clean study design. This guide covers the hormones, the five receptors, the four compounds, and how to use selectivity to get interpretable results.

The Hormones

All melanocortins come from one precursor protein, pro-opiomelanocortin (POMC), which is cut into different pieces in different tissues. In the pituitary it yields ACTH (39 residues), the adrenal-stimulating hormone. In the hypothalamus and skin it yields alpha-MSH (13 residues, acetylated and amidated), the melanocyte-stimulating hormone that also regulates incretin-pathway and inflammation. Beta- and gamma-MSH are additional fragments with their own receptor preferences. The system also has two natural antagonists, agouti and agouti-related protein (AgRP), which block receptors rather than activating them, an unusual arrangement that lets the body tune melanocortin signaling in both directions.

The Receptor Map

All five melanocortin receptors are G-protein-coupled receptors that raise cyclic AMP when activated.

The Research Compounds

Melanotan 1 is the selective probe: a linear alpha-MSH analog with two substitutions (norleucine at position 4 and D-phenylalanine at position 7) that protect it from enzymatic breakdown and increase potency. It retains alpha-MSH’s strong MC1R preference, making it suited to pigmentation-focused designs and to studies of MC1R on immune cells. It is about 1,647 Da.

Melanotan 2 is the broad probe: a cyclic heptapeptide analog, closed by a lactam bridge between side chains, that engages MC1R, MC3R, MC4R, and MC5R with high affinity. The cyclization makes it potent and stable but removes selectivity, which is useful when mapping cross-receptor effects and a confound when a specific receptor is the question. About 1,024 Da.

PT-141 (bremelanotide) is derived from Melanotan 2 by converting the C-terminal amide to a free acid. That small change shifts the profile toward MC4R and MC3R while reducing MC1R-driven pigmentation, and the compound anchors central melanocortin research on sexual function and energy balance. About 1,025 Da.

KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH. It carries alpha-MSH’s anti-inflammatory activity (reduced NF-κB activation and cytokine production) but does not activate MC1R-driven pigmentation, and much of its effect appears to be receptor-independent. It is studied in gut and skin inflammation models and is the anti-inflammatory component of our KLOW blend. About 343 Da.

Compound Structure MC1R MC3R MC4R MC5R Primary research use
Melanotan 1 Linear, 13 aa High Low Low Low Pigmentation, MC1R immunology
Melanotan 2 Cyclic, 7 aa High High High High Cross-receptor mapping
PT-141 Cyclic, 7 aa (free acid) Moderate High High Moderate Central MC4R signaling
KPV Linear, 3 aa Minimal Minimal Minimal Minimal Anti-inflammatory signaling

Why Selectivity Matters

Comparative designs across these four compounds let laboratories separate receptor-specific effects. If a result appears with Melanotan 2 but not Melanotan 1, it is unlikely to be MC1R-mediated. If it appears with PT-141 and Melanotan 2 but not Melanotan 1, MC3R or MC4R is implicated. If it appears with KPV, which barely activates any of the receptors, a receptor-independent mechanism is in play. The difference between a pigmentation result and an incretin-pathway-signaling result often comes down to which analog was chosen, and a well-designed study uses two or more to triangulate. Selective MC4R antagonists and the natural antagonist AgRP add a further layer where available.

Handling Notes

All four peptides are chemically robust: none contains methionine or cysteine (Melanotan 1 replaces alpha-MSH’s methionine with norleucine for that reason), and the cyclic compounds are resistant to proteases. Melanotan 1, 2, and PT-141 each contain a tryptophan and are light-sensitive; store solutions in the dark. Confirm identity by mass on the Certificate of Analysis; Melanotan 2 and PT-141 differ by only 1 Da (amide versus acid), so high-resolution mass spectrometry or HPLC retention time is needed to distinguish them. Reconstitute with bacteriostatic water, refrigerate, and use within a few weeks; see Storing Lyophilized Peptides. Browse the compounds in the Neuroendocrine & Receptor Research collection.

All products discussed are intended strictly for in-vitro research and laboratory use only. They are not for human or veterinary use, consumption, or therapeutic application.

Research use only. The compounds discussed on this blog are intended for in-vitro laboratory research. Nothing here is medical advice, and none of these materials are for human or veterinary use.

Research Materials

Compounds referenced in this article, each lot third-party tested with a Certificate of Analysis.

Melanotan 1 Neuroendocrine & Receptor Research Melanotan 1 View product → Melanotan 2 Neuroendocrine & Receptor Research Melanotan 2 View product → PT-141 Neuroendocrine & Receptor Research PT-141 View product → KPV Tissue & Cell Migration Research KPV View product →

Compound data: Melanotan 1 data sheet Melanotan 2 data sheet PT-141 data sheet KPV data sheet All data sheets →

Keep Reading

Molecular structure comparison of tesamorelin and sermorelin for laboratory research.
November 18, 2026

Tesamorelin vs. Sermorelin: Research Differences

Read →
In vitro receptor signaling research comparing ipamorelin and GHRP-6 pathways.
November 16, 2026

Ipamorelin vs. GHRP-6: Research Differences

Read →
Best Third
November 12, 2026

Best Third-Party Tested Peptides for Research Labs

Read →

← All Articles